Panelists discuss how IDH inhibitors, particularly ivosidenib combined with azacitidine, represent potentially the greatest advance in AML treatment due to significant overall survival improvements, ...
According to the 2023 Public Edition of the Basel AML Index, the average global money laundering (ML) and terrorist financing (TF) risk level increased from 5.25 in 2022 to 5.31 in 2023, where 10 is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results